Second Sight Medical Products Growth, Revenue, Number of Employees and Funding
Estimated Revenue & Financials
- Second Sight Medical Products's estimated revenue is currently $34.9M per year.
- Second Sight Medical Products received $4.0M in venture funding in October 2018.
- Second Sight Medical Products's estimated revenue per employee is $234154
- Second Sight Medical Products has 149 Employees.
- Second Sight Medical Products grew their employee count by -11% last year.
- Second Sight Medical Products currently has 1 job openings.
|David Marsh||Senior Director, Software Engineering|
|Ted Randolph||VP of Manufacturing|
|Victoria Wilinski||Director of Materials|
|Mark Loar||Sr. Director, Regulatory Affairs|
|Jianing Wei||Director of Field Clinical Engineering|
|James Miller||Director of Manufacturing|
|John Blake||Chief Financial Officer|
|Victoria Alaverdian||Sr. Director of Quality|
|Jeff Wells||Director of Business Development|
|Paul Brathwaite||Senior Director, Research & Development (Externals)|
What Is Second Sight Medical Products?
Second Sight's mission is to restore useful vision to the blind and visually impaired. Second Sight is the leader in neuromodulation devices to treat blindness, with the most advanced technology platform delivering groundbreaking artificial vision. The recognized leader in retinitis pigmentosa, the company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. Second Sight's Argus II retinal prosthesis system is an FDA and CE approved device that delivers durable, useful vision to people with severe to profound retinitis pigmentosa (RP). The Argus II has been implanted in over 300 patients worldwide, with proven durability beyond 10 years The Argus II is the standard of care for patients with severe RP, with over 25 exclusive regional centers offering the technology across North America The company is actively developing a cortical stimulation device that bypasses the diseased eye and has the potential to provide a new form of vision to individuals blinded due to a wide range of causes. If you would like to learn more about Second Sight® Medical Products or the Argus® II Retinal Prosthesis System, you can reach us at (800)350-7060.keywords:Biotechnology,Healthcare,Medical Devices,Pharmaceuticals
Number of Employees
Employee Growth %
|Name||Revenue||Number of Employees||Employee Growth||Total Funding|
|Centro Medico D...||$19.8M||85||9%|
Second Sight Medical Products News
So shareholders might well want to know whether insiders have been buying or selling shares in Second Sight Medical Products, Inc.
Vuzix, Second Sight Medical Products, Samsung Electronics, Raytheon, Magic Leap, Google, Ekso Bionics Holdings, Braingate, B-Temia.
Second Sight Medical Products, Inc. (NasdaqCM:EYES) boasts a Price to Book ratio of 4.937015. This ratio is calculated by dividing the current ...
Second Sight Medical Products Funding
|2016-06-02||$19.4M||Undisclosed||Broadridge Corporate Issuer Solutions, Inc||Article|
Second Sight Medical Products Executive Hires
|2016-03-25||Steven D Okland Jr||VP Commercial U.S & Canada||Article|
|2017-03-03||David Jacques||Vice President of Research and Development||Article|
|2017-10-20||Frank Vandeputte||vp/General Manager, EMEA and Asia Pacific||Article|